PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Lung Cancer10.1016/s0169-5002(19)30249-12019127S85Treatment patterns and outcomes for limited stage small cell lung cancer treated with chemoradiotherapyD. Sim, A. Pascoe, K. Fowerakerhttps://api.elsevier.com/content/article/PII:S0169500219302491?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500219302491?httpAccept=text/plain
Annals of Oncology10.1093/annonc/mdy445.007201829ix141Chemotherapy versus combined chemoradiotherapy: Survival patterns among elderly patients with limited stage small cell lung cancerS. Abdulazizhttps://api.elsevier.com/content/article/PII:S0923753419434297?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419434297?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/29/suppl_9/mdy445.007/26698834/mdy445.007.pdf
Lung Cancer10.1016/0169-5002(96)85954-x1996141175Early alternating chemotheapy and radiotherapy schedule in limited disease stage small cell lung cancerhttps://api.elsevier.com/content/article/PII:016950029685954X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016950029685954X?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(03)92025-3200341S105P-56 Early concurrent normo- and hyperfractionated chemoradiotherapy in limited small cell lung cancer (LSCLC). Experience with 34 treated patientsZdenek Skacel, Miloslav Marel, Roman Pajdlhauser, Bela Malinova, Jana Prausova, Katerina Kosatovahttps://api.elsevier.com/content/article/PII:S0169500203920253?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500203920253?httpAccept=text/plain
Cancer Immunology, Immunotherapy10.1007/s00262-021-02929-0202170102877-2879Correction to: Effect of chemoradiotherapy on the proportion of circulating lymphocyte subsets in patients with limited‑stage small cell lung cancerYamei Chen, Ying Jin, Xiao Hu, Ming Chenhttps://link.springer.com/content/pdf/10.1007/s00262-021-02929-0.pdf, https://link.springer.com/article/10.1007/s00262-021-02929-0/fulltext.html, https://link.springer.com/content/pdf/10.1007/s00262-021-02929-0.pdf
Lung Cancer10.1016/0169-5002(94)91712-4199410S338-S339Delayed chest irradiation for patients with limited stage (LS) small cell lung cancer (SCLC)https://api.elsevier.com/content/article/PII:0169500294917124?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500294917124?httpAccept=text/plain
British Journal of Cancer10.1038/s41416-020-01070-62020123S110-17Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancerJohn Conibear, http://www.nature.com/articles/s41416-020-01070-6.pdf, http://www.nature.com/articles/s41416-020-01070-6, http://www.nature.com/articles/s41416-020-01070-6.pdf
Community Oncology10.1016/s1548-5315(11)70578-2201078362-365Concurrent chemoradiotherapy for the synchronous presentation of limited-stage small cell and early-stage non-small cell lung cancersJohn M. Watkins, Michael A. Yehl, David Holloman, Anand K. Sharmahttps://api.elsevier.com/content/article/PII:S1548531511705782?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1548531511705782?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(97)83929-3199718112Chemoradiotherapy for stage III non-small cell lung cancerEverett E. Vokeshttps://api.elsevier.com/content/article/PII:S0169500297839293?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500297839293?httpAccept=text/plain
Lung Cancer10.1007/0-387-22652-4_102003186-206Treatment of Limited-Stage Small Cell Lung CancerRitsuko Komakihttp://link.springer.com/content/pdf/10.1007/0-387-22652-4_10